Opendata, web and dolomites

GNU200

Innovative Solution in Microbiome Modulation to Benefit Infant Healthy growth

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GNU200 project word cloud

Explore the words cloud of the GNU200 project. It provides you a very rough idea of what is the project "GNU200" about.

gos    meat    obesity    gnu    function    choose    infant    breast    child    gastrointestinal    industry    lack    breastfeed    prebiotics    though    restores    serve    thought    mimicking    hmos    explained    birth    market    alternative    despite    indicates    concentration    protect    substantially    brain    found    prevents    immune    shape    milk    poor    gnubiotics    microbiota    opportunity    mix    intelligence    human    nature    business    alternatives    efficacy    200    employed    reduces    ahead    probability    substitutes    reinforce    protects    composition    hence    similarly    components    fledgling    antibiotics    start    benefits    rates    diet    population    adding    feed    compensate    fos    replicate    healthy    parents    closer    prebiotic    mimics    abundant    fundamental    breastfeeding    infants    female    home    declining    naturally    minimal    babies    oligosaccharides    diabetes    campaigns    natural    onset    inconvenience    treatment    infections    formulae    overweight    scientific    malocclusion    diversity    molecules    proven    diseases   

Project "GNU200" data sheet

The following table provides information about the project.

Coordinator
GNUBIOTICS SCIENCES SARL 

Organization address
address: ROUTE DE LA CORNICHE 4
city: EPALINGES
postcode: 1066
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://www.gnubiotics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy)
2. H2020-EU.3.2.1. (Sustainable agriculture and forestry)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2018-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GNUBIOTICS SCIENCES SARL CH (EPALINGES) coordinator 50˙000.00

Map

 Project objective

Despite declining birth rates and the increasing number of campaigns to promote and support breastfeeding, the market for infant milk substitutes is growing. This is explained by the increasing employed female population, as well as inconvenience to breastfeed out of home. Scientific evidence indicates that breastfeeding protects against child infections and malocclusion, increases intelligence, and reduces overweight and diabetes’ probability. As an alternative to breastfeeding, parents choose to feed their babies with infant milk formulae that cannot replicate the effects and benefits of breast milk because fundamental components such as prebiotic human milk oligosaccharides (HMOs) are not included. To compensate for this lack of HMOs, oligosaccharides such as GOS and FOS are included, even though they are poor mimics of HMOs with minimal evidence of efficacy. HMOs, the third most abundant component in breast milk, are molecules naturally tailored to the need of an infant which serve as prebiotics that help shape microbiota composition, protect infants from diseases, foster healthy gastrointestinal systems, reinforce fledgling immune function, and promote early brain development. Adding HMOs in formulae will substantially improve child benefits, mimicking breast milk composition (bringing formulae closer to nature).

We, GNUbiotics, are a start-up that has developed GNU 200 thought a process based on a by-product from the meat industry. This natural prebiotic composed of a mix with high diversity and concentration of oligosaccharides with proven efficacy. Our product protects against infections, restores the microbiota diversity after antibiotics treatment and prevents the onset of diet induced obesity similarly to HMOs found in breast milk. Hence, it represents a great business opportunity several steps ahead than alternatives.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GNU200" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GNU200" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)

Stoock (2018)

An Innovative Integrated Field Sensor system providing a precise farming tool to reduce productioncosts and water wastage.

Read More  

TEST4ALL (2018)

ANTIBIOTICS CONTROL FOR ALL

Read More  

FucoPol (2017)

An innovative bio-based platform for the cost-competitive production of L-fucose, a building block for Human Milk Oligosaccharides (HMOs).

Read More